Please select an option below to help us tailor your newsletter to best suit your content interests!
West Cancer Center’s Executive Director, Lee Schwartzberg, MD, FACP presented key findings from a phase III study at the Multinational Association of Supportive Care in Cancer (MASCC) Annual meeting held in Vienna, Austria, June 28-30. He was lead investigator for the study titled “Eflapegrastim is Safe and Effective in Reducing Severe Neutropenia in Patients Receiving… Read more »
Just what the doctor ordered! Every great city demands great doctors. Although adequate funding and state-of-the-art facilities play an important role in developing viable medical care, it is the ingenuity and dedication of great medical minds that truly raise the bar. Our West Cancer Center doctors have been recognized for their dedication to medical research… Read more »
We are very proud of the recent article by W. Clay Jackson, MD, DipTh, one of our Palliative Care Physicians, in the Pain Practitioner Summer 2018 issue. A Treatment Choice – a patient’s perspective.
Check out the recent Local Memphis Top Story interview with Dr. Pallera on newly released findings about treatment for early stage breast cancer! For the full TV interview, please Click Here. “This study, which never would have happened without federal funding for cancer research, will transform care immediately, and for the better. These data… Read more »
James Grayson: The Stigma of Burnout Is Gone and Focus Should Be on the Future While burnout is being acknowledge much better today, it has been getting worse and there should also be focus on what burnout will look like 20 or 30 years from now, said James Grayson, administrative chief of staff at West… Read more »
West Cancer Center had an impressive presence at the American Society of Clinical Oncology Annual Meeting. Lee Schwartzberg: Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay. In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response… Read more »
March marks national Colorectal Cancer Awareness Month. It’s particularly important for the Mid-south, which ranks as one of the worst for colon cancer deaths, but researchers say it can be easily treated, if caught early. The disease affects around 140,000 people per year. “If you put men and women together, it’s the second leading cause… Read more »
West’s very own, Dr. Arun Rao, was featured in the West TN Medical News – March Issue for his work in rural areas of our region. “The people are so welcoming and appreciative of all we do. I love being able to provide oncology and hematology care to this community.” We love Dr. Rao and… Read more »
HIPEC is a treatment modality for patients with peritoneal carcinomatosis. Patients who develop peritoneal carcinomatosis include those patients with appendiceal tumors, certain colon cancers, ovarian cancers as well as mesothelioma. There are some pediatric sarcomas as well which are commonly affected by peritoneal carcinomatosis. Historically these patients will be treated with surgery, chemotherapy, but the… Read more »
Join OncLive on Friday, January 26 at 2pm for a live broadcasted discussion of Major Breast Cancer Challenges of 2018 featuring expert insights from the leading minds in oncology. West Cancer Center’s Dr. Lee Schwartzberg will join Kimberly Blackwell, MD; Adam Brufsky, MD, PhD; and Hope Rugo, MD to review 2017’s most impactful breast cancer… Read more »